Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation
geralt / Pixabay

Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation

According to a story from prnewswire.com, the biopharmaceutical company Aridis Pharmaceuticals, Inc. has recently announced that the US Food and Drug Administration (FDA) has awarded Orphan Drug designation to the…

Continue Reading Potential Treatment for Cystic Fibrosis Lung Infections Earns Orphan Drug Designation